Evidence map›Paper›PMID 25591808›Full record

ArticleCancer gene therapy2015

Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells.

W Zang, T Wang, J Huang, M Li, Y Wang, Y Du, X Chen, G Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Cancer gene therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Exosome-mediated lnc-ABCA12-3 promotes proliferation and glycolysis but inhibits apoptosis by regulating the toll-like receptor 4/nuclear factor kappa-B signaling pathway in esophageal squamous cell carcinoma.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Aging · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

W ZangCollege of Basic Medical Sciences, Zhengzhou University, Zhengzhou, People's Republic of China.
T WangDepartment of Hemato-tumor, The First Affiliated Hospital of Henan University of TCM, Zhengzhou, People's Republic of China.
J HuangCollege of Basic Medical Sciences, Zhengzhou University, Zhengzhou, People's Republic of China.
M LiCollege of Basic Medical Sciences, Zhengzhou University, Zhengzhou, People's Republic of China.
Y WangCollege of Basic Medical Sciences, Zhengzhou University, Zhengzhou, People's Republic of China.
Y DuCollege of Basic Medical Sciences, Zhengzhou University, Zhengzhou, People's Republic of China.
X ChenCollege of Basic Medical Sciences, Zhengzhou University, Zhengzhou, People's Republic of China.
G ZhaoCollege of Basic Medical Sciences, Zhengzhou University, Zhengzhou, People's Republic of China.
Zhengzhou University · CNFirst Affiliated Hospital of Henan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long chain noncoding RNAs (LncRNAs), a class of noncoding RNA nucleotides longer than 200 bp, have important roles in a variety of biological processes. Accumulating evidence has confirmed the involvement of LncRNAs in cancer initiation, development and progression. We investigated the expression of LncRNA PEG10 in a cohort of esophageal carcinomas to assess its impact on esophageal cancer cell proliferation, apoptosis and invasion. Quantitaive reverse transcription polymerase chain reaction assays were used to quantify LncRNA PEG10 expression levels in 43 paired EC samples and adjacent non-neoplastic tissues. Cell growth, apoptosis and Transwell invasion assays were used to evaluate the effects of LncRNA PEG10 on esophageal cancer cells. LncRNA PEG10 was expressed at higher levels in esophageal cancer tissues than in adjacent non-neoplastic tissues (P<0.05). This relatively high expression was significantly associated with the occurrence of lymph node metastases (P<0.05). Apoptosis and migration rates were significantly decreased in two esophageal cancer cell lines (EC9706 and KYSE150) transfected with si-LncRNA PEG10 (P<0.05). Downregulation of LncRNA PEG10 decreased the expression of PEG10 (P<0.05). Our results indicated that LncRNA PEG10 is upregulated in esophageal cancer tissues, and its downregulation inhibits proliferation and invasion, and promotes apoptosis in esophageal cancer cells. LncRNA PEG10 may serve as a therapeutic agent in esophageal cancer.

Indexed as

Cell ProliferationApoptosisCarcinoma, Squamous CellEsophageal NeoplasmsFemaleGene ExpressionGene Knockdown TechniquesHumansLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessOrgan SpecificityRNA, Long NoncodingPEG10 non-coding RNA, humanRNA, Long Noncoding

Identifiers

PMID25591808
OpenAlexW2037301602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.